https://www.businesswire.com/news/home/20250225949774/en/MEDSIR-Debiopharm-Announce-the-First-Patient-Dosed-in-the-WIN-B-Trial-Exploring-the-Combination-of-Debio-0123-Gilead%E2%80%99s-Trodelvy%C2%AE-in-Advanced-Breast-Cancer
Gilead

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service